The Economics of Glaucoma Care in 2025: Screening, Devices, and Drugs
Introduction Glaucoma affects tens of millions worldwide and is the second leading cause of irreversible blindness after cataract (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Most cases progress silently, and roughly 3% of adults over 40 have glaucoma – the majority undiagnosed (pmc.ncbi.nlm.nih.gov). Visual loss from glaucoma heavily degrades quality of life and raises lifetime costs; one s...